Patients' preferences for osteoarthritis treatment: the value of stated-preference studies.
Hiligsmann MDepartment of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. m.hiligsmann@maastrichtuniversity.nl.
Pinto DDepartment of Physical Therapy, Marquette University, Milwaukee, USA.
Dennison EMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, England, UK.
Al-Daghri NPrince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Beaudart CDepartment of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Branco JRheumatology Department, CEDOC-NOVA Medical School, Faculdade de Ciências Médicas da Universidade Nova de Lisboa, CHLO, Hospital Egas Moniz, Lisbon, Portugal.
Bruyère ODepartment of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Conaghan PGLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK.
Cooper CMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, England, UK.
Jiwa FChair of the Committee of Patients Societies at the International Osteoporosis Foundation, Osteoporosis Canada, Toronto, Canada.
Lems WVU University Medical Center, Amsterdam, The Netherlands.
Rizzoli RGeneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Thomas TDepartment of Rheumatology, Nord Hospital, University Hospital of St-Etienne, INSERM 1059, University of Lyon, Saint-Étienne, France.
Veronese NNeuroscience Institute, Aging Branch, National Research Council, Padua, Italy.
Reginster JYPrince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.